Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates

Abstract Background Clinically significant portal hypertension (CSPH) has been identified as an important prognostic factor in patients with hepatocellular carcinoma (HCC) undergoing curative treatment. This study aimed to assess PH estimates as prognostic factors in patients with HCC treated with i...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lukas Müller, Simon J. Gairing, Friedrich Foerster, Arndt Weinmann, Jens Mittler, Fabian Stoehr, Dirk Graafen, Christoph Düber, Peter R. Galle, Roman Kloeckner, Felix Hahn
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-04-01
Col·lecció:	Cancer Imaging
Matèries:	Hepatocellular carcinoma Prognosis Immunotherapy Portal hypertension
Accés en línia:	https://doi.org/10.1186/s40644-023-00558-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!